$500 – $1,000 Paid Clinical Trials
440 studies
Short outpatient Phase 1 studies and multi-visit observational studies often compensate in the $500–$1,000 range.
Compensation amounts shown are typical ranges for this study type — not guaranteed amounts. Actual compensation is set by each study sponsor and documented in the informed consent form. ClinicalTrials.gov does not include a structured compensation field.
Showing 121–140 of 440 studies
Recruiting
Phase 1
Drug-Drug Interaction Study of Atumelnant in Healthy Participants
Healthy Volunteers
Crinetics Pharmaceuticals Inc.46 enrolled1 locationNCT07570082
Recruiting
Phase 1
A Study of SYNT-101 to Test Safety, Tolerability and Pharmacodynamics of SYNT-101 in Healthy and Overweight Adults
HealthyOverweight and Obese Adults
Syntis Bio64 enrolled1 locationNCT07307274
Recruiting
Phase 1
A Drug-Drug Interaction Study of Itraconazole and Opevesostat (MK-5684) in Healthy Adult Male Participants (MK-5684-017)
Healthy
Merck Sharp & Dohme LLC14 enrolled1 locationNCT07548606
Recruiting
Phase 1
A Phase 1 Study to Assess the Effect of ABBV-722 on Midazolam, Digoxin, Pitavastatin, Metformin, and Sitagliptin Drug Levels in Healthy Adults.
Healthy Volunteers
AbbVie12 enrolled1 locationNCT07567781
Recruiting
Phase 1
A Study to Learn About a Vaccine Against E Coli in Healthy Adults
Healthy Participants
Pfizer310 enrolled11 locationsNCT07122986
Recruiting
Phase 1
Study of the Safety, Tolerability, Pharmacokinetics of VV913 Capsules in Chinese Healthy Participants
Healthy Volunteers
Vigonvita Life Sciences56 enrolled1 locationNCT07372703
Recruiting
Phase 1
A Study to Assess the Bioequivalence of Trastuzumab Via Different Subcutaneous Delivery Platforms in Healthy Male Participants
Healthy Participants
Genentech, Inc.312 enrolled4 locationsNCT07214766
Recruiting
Phase 1
The Primary Purpose of This Study is to Determine if Biotin, Vitamin B7 is an Effective Way to Label Platelets in Survival and Recovery Studies.
Healthy Volunteers
Bloodworks12 enrolled1 locationNCT07513532
Recruiting
Phase 1
A Phase 1 Study of BLKR201 in Healthy Adult Participants
Healthy
Formation Bio, Inc.128 enrolled1 locationNCT07501039
Recruiting
Phase 1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics of GenSci161 in Healthy Adult Participants
Healthy Volunteers
Changchun GeneScience Pharmaceutical Co., Ltd.44 enrolled1 locationNCT07476586
Recruiting
Phase 1
A Study in Healthy Men to Test How Well Different Doses of BI 3821001 Are Tolerated
Healthy
Boehringer Ingelheim72 enrolled1 locationNCT07526194
Recruiting
Phase 1
OMAR Opioid Use Disorder
Healthy ControlOpioid-use Disorder
Yale University30 enrolled1 locationNCT05683184
Recruiting
Phase 1
A Study to Learn How the Body Processes BIIB141 (Omaveloxolone) When Taken as a Capsule or as a Tablet Dissolved in Liquid, and to Learn About Its Safety in Healthy Adults Ages 18 to 55
Healthy Volunteer
Biogen70 enrolled1 locationNCT07297199
Recruiting
Phase 1Phase 2
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Healthy Volunteers, Pulmonary Arterial Hypertension
Novartis Pharmaceuticals232 enrolled85 locationsNCT06649110
Recruiting
Phase 1
A Phase 1 Study to Assess the Effect of ABBV-722 on Ethinyl Estradiol and Levonorgestrel Drug Levels in Healthy Adult Female Participants
Healthy Volunteer
AbbVie16 enrolled1 locationNCT07502417
Recruiting
Phase 1
A Study to Evaluate the Safety, Tolerability, PK/PD of HEC-007 Injection in Healthy and Overweight/Obese Subjects
Healthy Subjects
Sunshine Lake Pharma Co., Ltd.126 enrolled1 locationNCT07102251
Recruiting
Phase 1
A Study to Investigate Andexanet Dosing and the Interaction Between Andexanet and Subsequent Enoxaparin in Healthy Participants
Healthy Participants
AstraZeneca186 enrolled2 locationsNCT07312851
Recruiting
Phase 1
Study to Evaluate the Safety, Tolerability and How IBI3013 is Taken up and Processed by the Body in Healthy Volunteers After Single-dose Administration, and in Non-segmental Vitiligo Patients and Alopecia Areata Patients After Multiple-dose Administration
HealthySevere Alopecia AreataActive Non-segmental Vitiligo
Innovent Biologics (Suzhou) Co. Ltd.160 enrolled1 locationNCT07554222
Recruiting
Phase 1
Single-ascending Dose Study of HEC-151 Injection
Healthy Adult Male
Sunshine Lake Pharma Co., Ltd.81 enrolled2 locationsNCT07376200
Recruiting
Phase 1
A Study to Investigate the Pharmacokinetics of Different Formulations and Safety of AZD5004 in Healthy Participants Aged 18 to 55 Years
Healthy Participants
AstraZeneca64 enrolled2 locationsNCT07455825